Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Metadata
Title
Adrenomedullin: Multiple functions in human pregnancy
Authors
Caroline Wilson
Leonid L. Nikitenko
Ian L. Sargent
Margaret C. P. Rees
Publication date
01-09-2004
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 3/2004
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-004-4183-5

Other articles of this Issue 3/2004

Angiogenesis 3/2004 Go to the issue

OriginalPaper

A highly efficient electroporation method for the transfection of endothelial cells

OriginalPaper

Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment

Review

Angiogenic growth factors and hypertension

OriginalPaper

Placenta growth factor is not required for exercise-induced angiogenesis

OriginalPaper

The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels

OriginalPaper

Heterophilic interactions between cell adhesion molecule L1 and αv β3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits